Medical technology is developing rapidly, with innovative technologies playing a key role in improving patient care. An outstanding example of this is the collaboration between Fraunhofer EMFT and the Japanese medical technology company Daiken Medical. At the heart of this partnership is the development and successful licensing of the world's smallest micromembrane pump, which not only revolutionizes the possibilities of microdosing, but also paves the way for new applications in pain therapy. A significant step in this process was the technology transfer of the patented micro-membrane pump from Fraunhofer EMFT to the medium-sized company Daiken Medical in Osaka, which is now advancing the PCA system "Amy," enabling patients to control their pain treatment themselves.